Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera
Clinical trial NCT06193408 · COMPLETED
Trial details
- NCT number
- NCT06193408
- Sponsor
- Hunazine Biotech S.L.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-11
- Primary completion
- 2024-08-11
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.